Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript

Longeveron Inc. (NASDAQ:LGVN) Q1 2024 Earnings Conference Call May 14, 2024 5:00 PM ET

Company Participants

Derek Cole - IR, Advisory Solutions
Wa'el Hashad - CEO
Nataliya Agafonova - Chief Medical Officer
Lisa Locklear - CFO
Joshua Hare - Co-Founder, Chief Science Officer and Chairman of the Board

Conference Call Participants

Ram Selvaraju - H.C. Wainwright

Operator

Good day, ladies and gentlemen, and welcome to Longeveron 2024 First Quarter Financial Results Earnings Call. [Operator Instructions] Please note that this conference call is being recorded.

I would now like to turn the conference over to Derek Cole of Investor Relations Advisory Solutions. You may begin, sir.

Derek Cole

Thank you, Judith. Good afternoon, everyone, and thank you for joining us today to review Longeveron's first quarter 2024 financial results and business update. After the U.S. markets closed today, we issued a press release with financial results in the first quarter, which can be found under the Investors section of the Longeveron website.

On the call today are Wa'el Hashad, Chief Executive Officer; Dr. Nataliya Agafonova, Chief Medical Officer; Lisa Locklear, Chief Financial Officer; and Joshua Hare, Co-Founder, Chief Science Officer and Chairman of the Board.

As a reminder, during this call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from these statements. Any such statements should be considered in conjunction with cautionary statements in our press releases and risk factors discussed in the company's filings with the Securities and Exchange Commission, which we encourage you to review. Following the company's prepared remarks, we will open the call to questions from covering analysts.

With that, let me hand the call over to Wa'el Hashad, Chief Executive Officer. Wa'el?

Wa'el Hashad

Thank you, Derek. Good afternoon, everyone.

We